MedPath

This is a study in which we will compare how easily we can pass an endotracheal tube through two devices namely The I-Gel and The Blockbuster LMA respectively in patients who are undergoing operation under general anaesthesia.

Not Applicable
Not yet recruiting
Conditions
Calculus of gallbladder with acutecholecystitis,
Registration Number
CTRI/2019/12/022336
Lead Sponsor
Department of Anaesthesiology
Brief Summary

Airway management is the cornerstone of anaesthesia practice and the prime responsibility of the anaesthesiologist. Securing an adequate airway and ventilation is of utmost importance in patients undergoing surgeries under general anaesthesia. Tracheak intubation is the gold standard method for  maintaining a patent airway during anaesthesia since the introduction of endotracheal tube by Mc Ewan.

However this manoeuvre requires skill and continuous training.

Suprraglottic airway devices are intrinsically more invasive than the use of a face mask for anaesthesia, but less invasive than the tracheal intubation.

The I-Gel is a single use SAD. It does not have an inflatable cuff, made from a soft gel like and transparent thermoplastic elastomer(styrene ethylene butadiene styrene), it creates a non inflatable seal which is a mirror impression of the supraglottic anatomy. It has specific design features. I-Gel has also been usd as a conduit for tracheal intubation and in rescue airway management.

The supraglottic airway device Blockbuster is a second generation supraglottic device. The device is pharyngeally inserted airway device with an anatomically shaped airway tube. This modified form of supraglottic airway device has been specially designed to fascilitate blind tracheal intubation.

The aim of this study is to evaluate the ease of blind tracheal intubation through the I-Gel vs The Blockbuster LMA during general anaesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients will be ASA I or ASA II scheduled for laparoscopic surgery under general anaesthesia with BMI 18.5-29.9 and Mallampati III and IV.

Exclusion Criteria
  • The patients will be excluded from the study if they present as Mallampatti I or II, ASA III-V or emergency status or if they meet any one of the contradiction criteria including: 1.
  • Obesity (BMI > 35kg/m2) 2.
  • Pregnancy 3.
  • History of gastric regurgitation, heart burn, ileus or "full stomach".
  • History of low pulmonary compliance or high pulmonary compliance.
  • Any Pharyngeal pathology.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome of this study is to compare the ease of the blind tracheal intubation among the two supraglottic airway devices : The Blockbuster LMA and the I-Gel and to look for various haemodynamic and airway parameter changes during the process while we successfully ventilate the patient.The various time points in this study will start from the successful insertion of the Endotracheal tube through the Supraglottic airway device(SAD) into the patients airway till the point where the endotracheal tube is removed along with the SAD. The various haemodynamic and airway dynamic parameters will be noted every three minutes over the period of time of the surgery.
To look for post intervention complications on device removal.The various time points in this study will start from the successful insertion of the Endotracheal tube through the Supraglottic airway device(SAD) into the patients airway till the point where the endotracheal tube is removed along with the SAD. The various haemodynamic and airway dynamic parameters will be noted every three minutes over the period of time of the surgery.
Secondary Outcome Measures
NameTimeMethod
Failure to intubate blindly through the Blockbuster LMA or the I-Gel.Every 30 seconds till airway is secured definitely.

Trial Locations

Locations (1)

Dr RPGMC Tanda

🇮🇳

Kangra, HIMACHAL PRADESH, India

Dr RPGMC Tanda
🇮🇳Kangra, HIMACHAL PRADESH, India
Dr Aryan Guleria
Principal investigator
9418495611
drguleria79@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.